Wealth Architects, LLC Amgen Inc Transaction History

Wealth Architects, LLC

$739 Million
Q1 2024

A detailed history of Wealth Architects, LLC transactions in Amgen Inc stock. As of the latest transaction made, Wealth Architects, LLC holds 2,024 shares of AMGN stock, worth $629,221. This represents 0.08% of its overall portfolio holdings.

Number of Shares

2,024

Previous 2,159 6.25%

Holding current value

$629,221

Previous $621,000 7.41%

% of portfolio

0.08%

Previous 0.09%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $36,297 - $43,815	-135 Reduced 6.25%	2,024 $575,000
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $56,509 - $63,749	-221 Reduced 9.29%	2,159 $621,000
Q3 2023 Nov 09, 2023	BUY	$218.65 - $271.46 $32,797 - $40,719	150 Added 6.73%	2,380 $639,000
Q2 2023 Aug 02, 2023	SELL	$214.27 - $253.37 $6,856 - $8,107	-32 Reduced 1.41%	2,230 $495,000
Q1 2023 Apr 21, 2023	SELL	$225.79 - $275.2 $23,707 - $28,896	-105 Reduced 4.44%	2,262 $546,000

Q4 2022 Feb 09, 2023	BUY	$229.03 - $291.01 $12,825 - $16,296	56 Added 2.42%	2,367 $621,000
Q3 2022 Oct 24, 2022	BUY	$224.46 - $253.15 $13,916 - $15,695	62 Added 2.76%	2,311 $521,000
Q2 2022 Jul 29, 2022	SELL	$230.71 - $256.74 $43,834 - $48,780	-190 Reduced 7.79%	2,249 $547,000
Q1 2022 May 17, 2022	BUY	$219.27 - $242.57 $58,106 - $64,281	265 Added 12.19%	2,439 $590,000
Q4 2021 Jan 19, 2022	SELL	$198.88 - $227.6 $12,330 - $14,111	-62 Reduced 2.77%	2,174 $489,000
Q3 2021 Nov 09, 2021	BUY	$212.27 - $248.7 $1,273 - $1,492	6 Added 0.27%	2,236 $475,000
Q2 2021 Aug 09, 2021	SELL	$233.58 - $259.14 $12,379 - $13,734	-53 Reduced 2.32%	2,230 $544,000
Q1 2021 Apr 29, 2021	SELL	$221.91 - $258.6 $8,432 - $9,826	-38 Reduced 1.64%	2,283 $568,000
Q4 2020 Jan 28, 2021	BUY	$216.38 - $257.67 $2,596 - $3,092	12 Added 0.52%	2,321 $534,000
Q3 2020 Nov 09, 2020	BUY	$234.65 - $260.95 $36,370 - $40,447	155 Added 7.2%	2,309 $587,000
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $9,099 - $11,166	-46 Reduced 2.09%	2,154 $508,000
Q1 2020 Apr 23, 2020	BUY	$182.24 - $241.7 $8,565 - $11,359	47 Added 2.18%	2,200 $446,000
Q4 2019 Jan 28, 2020	BUY	$189.21 - $243.2 $12,677 - $16,294	67 Added 3.21%	2,153 $519,000
Q3 2019 Oct 23, 2019	SELL	$174.11 - $208.62 $1,044 - $1,251	-6 Reduced 0.29%	2,086 $404,000
Q2 2019 Jul 12, 2019	BUY	$166.7 - $195.41 $11,002 - $12,897	66 Added 3.26%	2,092 $386,000
Q1 2019 May 01, 2019	BUY	$180.87 - $203.88 $11,213 - $12,640	62 Added 3.16%	2,026 $385,000
Q4 2018 Jan 17, 2019	SELL	$178.4 - $208.25 $5,530 - $6,455	-31 Reduced 1.55%	1,964 $382,000
Q3 2018 Oct 04, 2018	SELL	$185.29 - $208.89 $18,343 - $20,680	-99 Reduced 4.73%	1,995 $414,000
Q2 2018 Jul 19, 2018	BUY	$166.05 - $186.51 $18,763 - $21,075	113 Added 5.7%	2,094 $387,000
Q1 2018 Apr 13, 2018	SELL	$169.43 - $198.0 $16,943 - $19,800	-100 Reduced 4.81%	1,981 $338,000
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $348,130 - $397,471	2,081	2,081 $388,000

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Architects, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Architects, LLC with notifications on news.

Account

Wealth Architects, LLC Amgen Inc Transaction History